Runtime
01:00
Memorial Sloan-Kettering and IBM are collaborating on the development of a powerful tool built upon IBM Watson in order to provide medical professionals with improved access to current and comprehensive cancer data and practices.
Watson's capability to analyze huge volumes of data and reduce it down to clinical decision points is absolutely essential for [us] to improve on our ability to deliver effective therapies,” says Memorial Sloan-Kettering President and CEO Craig B. Thompson.
